Ñòàæ: 18
Âðà÷ ïåðâîé êàòåãîðèè
Îêóëèñò (îôòàëüìîëîã)
Ïðèåì îò 3500

Âðà÷ ïðèíèìàåò â ñëåäóþùèõ êëèíèêàõ:

ïð-ä Áåðåçîâîé ðîùè ä. 12
 Àýðîïîðò  Õîðîøåâî  Çîðãå  Ïàíôèëîâñêàÿ  Õîðîøåâñêàÿ  ÖÑÊÀ
Íà êàðòå

Îáùèå ñâåäåíèÿ

  • Àìáóëàòîðíûé ïðèåì, äèàãíîñòèêà è ëå÷åíèå ãëàçíîé ïàòîëîãèè;
  • Ïðîâåäåíèå êîìïëåêñíîé äîïîëíèòåëüíîé äèàãíîñòèêè ïåðåä ÔÝÊ, à òàêæå ïåðåä ÝËÊ è ïîñëåîïåðàöèîîíîå âåäåíèå;
  • Èíòðàâèòðåàëüíûå èíúåêöèè;
  • Ëàçåðíûå ìåòîäû ëå÷åíèÿ (Ïàíðåòèíàëüíàÿ ËÊÑ, Ôîêàëüíûå ËÊÑ, Ïåðèôåðè÷åñêàÿ ËÊÑ, YAG - äèñöèçèÿ âòîðè÷íûõ ïëåí÷àòûõ êàòàðàêò);
  • Èíòðàâèòðåàëüíûå èíúåêöèè (áåâàöèçóìàá, ðàíèáèçóìàá, Àôëèáåðöåïò (EYLEA);
  • Õèðóðãè÷åñêèå ìåòîäû èõ ëå÷åíèå (íà÷àëüíûå ýòàïû âèòðåîðåòèíàëüíîé õèðóðãèè);
  • Âûâåäåíèå ñèëèêîíà;
  • Ïîâòîðíûå õèðóðãè÷åñêèå îïåðàöèè ïîñëå âèòðýêòîìèè, àññèñòåíöèÿ ïðè âèòðåîðåòèíàëüíûõ îïåðàöèÿõ;
  • ÔÝÊ.

Îáðàçîâàíèå

  • Äèïëîì ïî ñïåöèàëüíîñòè "Ëå÷åáíîå äåëî", Ëóãàíñêèé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò (2007 ã.)
  • Èíòåðíàòóðà ïî ñïåöèàëüíîñòè "Îôòàëüìîëîãèÿ", Ëóãàíñêàÿ îáëàñòíàÿ êëèíè÷åñêàÿ áîëüíèöà (2009 ã.)
  • Îðäèíàòóðà ïî ñïåöèàëüíîñòè "Îôòàëüìîëîãèÿ", Ëóãàíñêèé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò (2011 ã.)

Ïîâûøåíèå êâàëèôèêàöèè

  • "3nd Low Vision awareness course, Prague", Czech Republic (2009 ã.)
  • "Ëàçåðíûå ìåòîäû ëå÷åíèÿ ïàòîëîãèè ãëàçíîãî äíà", Öåíòð ìèêðîõèðóðãèè ãëàçà (2010 ã.)
  • "Îñîáåííîñòè èñïîëüçîâàíèÿ ôàêîýìóëüñèôèêàòîðîâ ïðîèçâîäñòâà «Àëêîí»" (2010 ã.)
  • "8th LECOP Diabetic Retinopathy Course" (2011 ã.)
  • "Took observership supported by SOE Educational Grant 2011", Department of Ophthalmology at the University Medical Center Hamburg-Eppendorf (2011 ã.)
  • "Dexamethasone intravitreal implant 0,7 mg Wet Lab", 11th Euretina, London (2011 ã.)
  • "Was completed open Access GCP Test with an examination score of 23/25: 92% PharmaXM" (2013 ã.)
  • "Èíòðàâèòðåàëüíûå è ñóáòåíîíîâûå èíúåêöèè", Èíñòèòóò ãëàçíûõ áîëåçíåé è òêàíåâîé òåðàïèè èìåíè Â. Ï. Ôèëàòîâà (2013 ã.)
  • "European VitreoRetinal Training School Bremen" (2013 ã.)
  • "Âèòðåîðåòèíàëüíàÿ õèðóðãèÿ" (2013 ã.)
  • "Ôàêîýìóëüñèôèêàöèÿ êàòàðàêòû" (2014 ã.)
  • "Intravitreal meeting at Clinic Pallas. Olten Switzerland. Bayer" (2014 ã.)
  • "Îôòàëüìîëîãèÿ", Êóáàíñêèé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò (2015 ã.)
  • "Îðãàíèçàöèÿ çäðàâîîõðàíåíèÿ è îáùåñòâåííîå çäîðîâüå", Êðûìñêèé ôåäåðàëüíûé óíèâåðñèòåò èìåíè Â.È. Âåðíàäñêîãî (2017 ã.)
  • "Ýêñèìåðëàçåðíàÿ êîððåêöèÿ çðåíèÿ" (2017 ã.)
  • "Paragon CRT for Corneal Refrective Therapy" (2018 ã.)

íàïèñàëà
î âðà÷å, â êëèíèêå:
Ìîñêâà, ïð-ä Áåðåçîâîé ðîùè ä. 12

Âðà÷ ðåøèëà ìîþ ïðîáëåìó, êîòîðóþ ÿ õîòåë. Ïîëó÷èë, ÷òî òðåáîâàëîñü. Ãóäêîâà Îëüãà Àëåêñååâíà âíèìàòåëüíàÿ. Âèçèò áûë ïîëåçåí ïðîâåäåííûì îáñëåäîâàíèåì.

âðà÷:
îòíîøåíèå:
êâàëèôèêàöèÿ:
öåíà-êà÷åñòâî:

Ñïåöèàëèçàöèÿ Âðà÷à

Ïîìîæåì íàéòè âðà÷à

Îñòàâüòå ñâîé íîìåð è ìû âàì ïåðåçâîíèì â òå÷åíèå 10 ìèíóò

Âû äåéñòâèòåëüíî õîòèòå
îòìåíèòü çàïèñü?

Åñëè ó âàñ âîçíèêëè âîïðîñû,
çàäàéòå èõ íàì ïî òåëåôîíó åäèíîé ñëóæáû çàïèñè
+7 (495) 152-85-63
èëè èñïîëüçóéòå